PD-1 inhibition enhances antitumor immunity, activates T-cell cytotoxicity against tumor cells, releases inflammatory cytokines and cytotoxic granules, and limits metastasis (Darvin et al., 2018). Here, PDCD1 is linked to neoplasm.